Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Copenhagen O, Denmark Clinical Trials

A listing of Copenhagen O, Denmark clinical trials actively recruiting patients volunteers.

RESULTS

Found (41) clinical trials

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias

Cerebellar ataxias (CA) and spastic paraplegias (SP) are genetically and clinically very heterogeneous. More than 40 loci are already known but the number of phenotypes is even greater suggesting further genetic heterogeneity. These progressive disorders are often severe and fatal, due to the absence of specific therapy. The SPATAX network ...

Phase

1.41 miles

Learn More »

Characterizing and Diagnosis s of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients

Method: The investigation is a case control study where the aim is to test a set off clinical tests to see if the diagnose Charcot foot can be made paraclinical. The assumption is, that there are other parameter than the clinical observation that differ between the Charcot patient and a ...

Phase N/A

1.41 miles

Learn More »

Interaction Between Immune Cells and Bacteria Associated With Periodontitis

Periodontitis is a prevalent, multifactorial inflammatory disease characterized by the interaction between microorganisms organized in biofilms on tooth surfaces and host immune cells, leading to an inflammatory destruction of the tooth-supporting tissues and - if left untreated - eventually tooth loss. Periodontitis affects up to 50% of the population in ...

Phase N/A

1.41 miles

Learn More »

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864). In the parent trial, patients will be subjected to an 8-week diet intervention phase including a low-calorie diet and dietetic counseling, after which. ...

Phase

2.0 miles

Learn More »

Mucopolysaccharidosis I (MPS I) Registry

The MPS I Registry is an international program; in addition to the central contact information provided under the "Location" heading, patients may contact: In Asia-Pacific - Vivian Liu, +65-6431-2548, Vivian.liu@genzyme.com In Europe - +31-35-699-1232, europe@mpsiregistry.com In Latin America - +617-591-5500, help@mpsiregistry.com In North America - +617-591-5500, help@mpsiregistry.com

Phase N/A

2.25 miles

Learn More »

Phase N/A

2.25 miles

Learn More »

Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet Copenhagen University Hospital

The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Phase N/A

2.25 miles

Learn More »

The Serotonergic Transmitter System in Dementia and Affective Disorders

The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography [PET]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.

Phase N/A

2.25 miles

Learn More »

Fabry Disease Registry

The Fabry Registry is an international program; in addition to the central contact information provided under the "Location" heading, patients may contact: In Asia-Pacific - Vivian Liu, +65-6431-2548, Vivian.liu@genzyme.com In Europe - +31-35-699-1232, europe@FabryRegistry.com In Latin America - +617-591-5500, help@FabryRegistry.com In North America - +617-591-5500, help@FabryRegistry.com

Phase N/A

2.25 miles

Learn More »

Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?

Background During facial cooling and especially during breath hold, can mammals - and also humans - elicit a so called dive reflex, causing bradycardia, peripheral vasoconstriction and centralization of blood flow to brain, lungs and heart (18 Foster et al 2005), but the reflex is suppressed by physical activity. The ...

Phase N/A

2.25 miles

Learn More »